Veraxa Biotech AG Ordinary Shares (VRXA) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · United States · ISIN KYG93A7H1041
Veraxa Biotech AG Ordinary Shares financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 CHF | 23,426.00 CHF |
| Gross profit | 0.00 CHF | 15,461.00 CHF |
| Operating income | -28.92 m CHF | -66.22 m CHF |
| EBIT | -28.75 m CHF | -67.00 m CHF |
| Net income | -28.13 m CHF | -66.61 m CHF |
| Diluted EPS – continuing operations | -0.20 CHF | -0.47 CHF |
Full history since 2023, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Veraxa Biotech AG Ordinary Shares
VERAXA Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation. The company utilizes proprietary payloads and genetic code expansion technology to engineer and manufacture homogeneous, stable bioconjugates with defined drug-to-antibody ratios. It also licenses technology platforms to support the development of new therapeutic strategies. The company serves professional clients in the healthcare sector, including those in drug development, biologicals, diagnostics, instrumentation, and partners with research organizations and business partners in the life sciences industry. The company was founded in 2021 and is based in Heidelberg, Germany.
More stocks
- Metro Mining Ltd (MMI.AX)
- Motonic (009680.KS)
- FATE THERAPEUTICS INC (FATE)
- X-Legend Entertainment Co Ltd (4994.TW)
- Seoul Broadcasting System (034120.KS)
- Shieh Yih Machinery Industry Co Ltd (4533.TWO)
- Seetel New Energy Co., Ltd. (7740.TW)
- NEXPOINT DIVERSIFIED REAL ESTATE TRUST (NXDT)
- Amplify Energy Corp. (AMPY)
- BrainChip Holdings Ltd (BRCHF)
- Admicom Oyj (ADMCM.HE)
- Topco Technologies (3388.TWO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.